These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 2200108

  • 1. [Immunosuppressive therapy of multiple sclerosis using cyclosporin A and azathioprine. Long-term effects, risks, proton spin tomography and immunological findings].
    Kappos L.
    Schriftenr Neurol; 1990; 32():1-200. PubMed ID: 2200108
    [No Abstract] [Full Text] [Related]

  • 2. Cyclosporine versus azathioprine in the long-term treatment of multiple sclerosis--results of the German multicenter study.
    Kappos L, Patzold U, Dommasch D, Poser S, Haas J, Krauseneck P, Malin JP, Fierz W, Graffenried BU, Gugerli US.
    Ann Neurol; 1988 Jan; 23(1):56-63. PubMed ID: 3278672
    [Abstract] [Full Text] [Related]

  • 3. [Efficacy and tolerance of cyclosporin A in the treatment of multiple sclerosis].
    Schluep M, Steck AJ, Despland PA, Regli F, Ochsner F, Berrut E, Gauthier G.
    Schweiz Rundsch Med Prax; 1991 Jun 11; 80(24):670-2. PubMed ID: 2068440
    [Abstract] [Full Text] [Related]

  • 4. Cyclosporine versus azathioprine in the treatment of multiple sclerosis: 12-month clinical and immunological evaluation.
    Steck AJ, Regli F, Ochsner F, Gauthier G.
    Eur Neurol; 1990 Jun 11; 30(4):224-8. PubMed ID: 2209678
    [Abstract] [Full Text] [Related]

  • 5. Magnetic resonance imaging in the evaluation of treatment in multiple sclerosis.
    Kappos L, Städt D, Ratzka M, Keil W, Schneiderbanger-Grygier S, Heitzer T, Poser S, Nadjmi M.
    Neuroradiology; 1988 Jun 11; 30(4):299-302. PubMed ID: 3050587
    [Abstract] [Full Text] [Related]

  • 6. [Long-term therapeutic trials and multiple sclerosis: a wager?].
    Confavreux C.
    Rev Neurol (Paris); 1983 Jun 11; 139(6-7):431-7. PubMed ID: 6412341
    [No Abstract] [Full Text] [Related]

  • 7. [Current studies of the effects of immunosuppressive agents on multiple sclerosis].
    Minderhoud JM.
    Ned Tijdschr Geneeskd; 1989 Jan 21; 133(3):99-100. PubMed ID: 2646546
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Therapeutic trials for multiple sclerosis.
    McKhann GM.
    Ann Neurol; 1990 Jun 21; 27(6):589-90. PubMed ID: 2193612
    [No Abstract] [Full Text] [Related]

  • 10. [Multiple sclerosis--current status of therapy].
    Reichel D, Kölmel HW.
    Z Arztl Fortbild (Jena); 1995 May 21; 89(2):151-8. PubMed ID: 7610682
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Immunosuppressive treatment in multiple sclerosis].
    Minderhoud JM, Prange AJ, Luijckx GJ.
    Ned Tijdschr Geneeskd; 1987 May 30; 131(22):966-7. PubMed ID: 3299110
    [No Abstract] [Full Text] [Related]

  • 13. Cyclosporine and multiple sclerosis: the cons.
    Rudge P.
    Neurology; 1988 Jul 30; 38(7 Suppl 2):29-30. PubMed ID: 3290712
    [Abstract] [Full Text] [Related]

  • 14. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ.
    Clin Ther; 2006 Apr 30; 28(4):461-74. PubMed ID: 16750460
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Long-term immunosuppression in multiple sclerosis: evaluation of treatments begun before 1972].
    Sabouraud O, Oger J, Darcel F, Madigand M, Merienne M.
    Rev Neurol (Paris); 1984 Apr 30; 140(2):125-30. PubMed ID: 6710012
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.